Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (5): 842-843    DOI: 10.12891/ceog4939.2019
Case Report Previous articles | Next articles
Pregnancy outcome following intentional ampicillin and pyridium overdose during the second trimester: a case report
I. Yilmaz1, *(), B. Karadas2, 3, S. Aydogmus4, E. Keskin-Arslan2, 3, H. Erol-Coskun2, 3, Y. C. Kaplan2, 3
1Department of Pharmacology and Toxicology, Health Sciences University, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey
2Department of Pharmacology, Izmir Kâtip Celebi University School of Medicine, Izmir, Turkey
3TERAFAR-Izmir Kâtip Celebi University Teratology Information, Training and Research Center, Izmir, Turkey
4Department of Obstetrics and Gynaecology, Izmir Kâtip Celebi University School of Medicine, Ataturk Research and Training Hospital, Izmir, Turkey
Download:  PDF(215KB)  ( 259 ) Full text   ( 8 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

There are no data focusing on the safety of overdose of ampicillin and pyridium during pregnancy. This study aims to report the outcome of a pregnant woman with an acute overdose of oral ampicillin+pyridium in the 14th week of pregnancy. A 27-year-old woman was referred to Teratology Information Service with a suicide history of ingesting 28 ampicillin+pyridium (500+50 mg) tablets. A structured, evidence-based counseling regarding her exposure to overdosing was provided, and she decided to continue her pregnancy. She gave birth to a baby in the 38th gestational week with fetal growth restriction (FGR), with no major congenital malformations and/or deformations. The follow-up of the infant in the 14th month of her life revealed normal physical and neurodevelopmental findings. Because the mother had no major risk factors and exposure of experimental animals to this overdosage have yielded comparable results, and the FGR in this case may be attributed to medication exposure.

Key words:  Ampicillin      Pyridium      Teratology Information Service      Pregnancy      Congenital malformations     
Published:  10 October 2019     
*Corresponding Author(s):  I. YILMAZ     E-mail:  driyilmaz@yahoo.com

Cite this article: 

I. Yilmaz, B. Karadas, S. Aydogmus, E. Keskin-Arslan, H. Erol-Coskun, Y. C. Kaplan. Pregnancy outcome following intentional ampicillin and pyridium overdose during the second trimester: a case report. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 842-843.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4939.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I5/842

[1] Mahvash Zargar, Razieh Pazhouhanfar, Mahin Najafian, Parastoo Moradi Choghakabodi. Effects of intrauterine autologous platelet-rich plasma infusions on outcomes in women with repetitive in vitro fertilization failures: a prospective randomized study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 179-184.
[2] Saipin Pongsatha, Theera Tongsong. Intravaginal misoprostol versus sublingual misoprostol for second trimester pregnancy termination: a randomized controlled trial[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 122-127.
[3] Eman A. Elhosary, Mahmoud M. Ewidea, Marwa A. Mohamed. Efficacy of kinesio tape on neck pain and functional disability in pregnant women: a randomized controlled trial[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 175-178.
[4] Xiao-Cen Niu, Li-Hua Zhu, Zhi-Da Qian, Li-Li Huang. Disseminated intravascular coagulation developed after suction curettage in an adenomyosis patient: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 189-193.
[5] Khac Tu Chau, Minh Tam Le, Doan Tu Tran, Vu Quoc Huy Nguyen. Uterine torsion in a 25-week pregnant female with congenital uterine didelphys and intraoperative complication of uterine atony: a report of a rare clinical case[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 185-188.
[6] Ji Eun Park, Ji Kwon Park, Hyun Chul Jo, In Ae Cho, Jong Chul Baek. The association between antenatal corticosteroid use in late-preterm and early-term pregnancy and nonreassuring fetal status[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 79-84.
[7] Jing-Jing Jiang, Ting Han, Yan-Hui Zhu. The early second-trimester multifetal pregnancy reduction improves pregnancy outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 164-167.
[8] Sureyya Saridas Demir, Erkan Cağliyan, Sabahattin Altunyurt. Retrospective analysis of pregnancy terminations and indications in a tertiary center[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 85-90.
[9] R. Mihăilă. Coagulation challenges in pregnancy: from thrombophilia involvement and management to the utility of thrombin generation monitoring[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 814-820.
[10] C.W. Kim, D.H. Lee, B.S. Joo, K.S. Lee. Successful cryopreservation of mouse and human blastocysts using vitrification solution without sucrose and Ficoll[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 847-855.
[11] E. Destegül, S. Gençdal, İ. Sarı, H. Akkaya, B. Çakmak, N. Gençdal. Maternal serum levels of SCUBE1 in missed abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 862-866.
[12] J.R. Huang, X. Li, Q.Z. Peng, J.J. Zhang, X.X. Lin, L.Q. Xie, X.H. Wu, W.S. Zhang. Elective embryo or fetal reduction for caesarean scar pregnancy combined with intrauterine pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 867-874.
[13] X.R. Wang, Y.F. Wang, S.W. Kang, Y. Zhang. Treatment outcomes of uterine lesion resection versus hysterectomy for cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 882-886.
[14] J.R. Huang, X. Li, C. Fu, Y.H. Deng, T. Gao, H.W. Zhang. Is preprocessing helpful for suction and curettage in treating cesarean scar pregnancy?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 900-905.
[15] L.B. Liu, H.T. Sun, S.F. Liu, R.X. Shi. Laparoscopy combined with hysteroscopy for cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 911-914.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[5] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[6] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[7] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[8] . SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51 -52 .
[9] Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68 -70 .
[10] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .